---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-079059"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:45:10.651882+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Janux shareholders elect three Class III directors and ratify EY as auditor

## Summary
- Class III directors elected: Vickie Capps, Jay Lichter, and Jake Simson, each with >41 million votes for.
- Ernst & Young ratified as independent auditor for FY2024 with 49,801,743 votes for, 1,682 against.
- 51,850,667 shares outstanding as of record date April 29, 2024; broker non-votes reported for director election.
- All proposals passed; no other business items were voted on at the 2024 annual meeting.

## SEC filing metadata
- accession: 0000950170-24-079059
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/0000950170-24-079059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/janx-20240626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-079059
- JSON: https://secwatch.observer/filing/0000950170-24-079059.json
- Plain text: https://secwatch.observer/filing/0000950170-24-079059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.